oxidised glutathione glucose 6 phosphate dehydrogenase defciency Glucose-6-Phosphate Deficiency and Cardiovascular Risk in Familial Hypercholesterolemia: A Retrospective Cohort Study Glucose-6-Phosphate Dehydrogenase Deficiency - Hematology/Oncology
Description
How can we put this number in perspective

Details SHOW SMILES / InChI SMILES OP(O)(O)=O.CC(C)CCNC1=C(C=CC=N1)C(=O)N2CCN(CC3=CC=CC=C3)CC2 InChI InChIKey=LWHMGALTTIYPJU-UHFFFAOYSA-N InChI=1S/C22H30N4O.H3O4P/c1-18(2)10-12-24-21-20(9-6-11-23-21)22(27)26-15-13-25(14-16-26)17-19-7-4-3-5-8-19;1-5(2,3)4/h3-9,11,18H,10,12-17H2,1-2H3,(H,23,24);(H3,1,2,3,4) NSI-189 is a novel oral drug which was developed by Neuralstem for the treatment of cognitive disorders
60073-2/asset/67a8baac-51a2-4f83-92b3-762e1e57d1f5/main.assets/gr1_lrg.jpg)
L-Glutathion Wirkung: Was das Master-Antioxidans fr deine Zellen leistet Wenn du dich mit Gesundheit und Langlebigkeit beschftigst, stt du unweigerlich auf L-Glutathion

26 and the references therein), they have limitations associated with well-known multiple adverse reactions, genotoxicity, and special requirements for storage, handling, and administration, posing challenges with respect to the standard operating procedure (SOP) for MDA campaigns requiring single or double dose activity, oral administration, minimal toxicity, and stability in tropical settings 27

Nausea 16-46%, diarrhea 16-26%, vomiting 8-22%
